Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Annual Information Update

27 May 2009 07:00

RNS Number : 8390S
PuriCore Plc
27 May 2009
 



PuriCore plc

Annual Information Update

MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 27 May 2009 - PuriCore (LSE: PURI), the life sciences company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, sets out below a list of the information that has been published or made available to the public over the previous 12 months, up to and including 27 May 2009.

The Company announces that, in accordance with Rule 5.2 of the Prospectus Rules, the following information was published or made available to the public during the 12-month period between 27 May 2008 and 27 May 2009. In accordance with Prospectus Rule 5.2.7, it is acknowledged that whilst the information referred to above was up to date at the time of publication, such disclosures may, at any time, become out of date due to changing circumstances. For the purposes of this update, the information is referred to rather than provided in full. Full copies of each item can be found in the locations specified below. 

 

1. Announcements made via the Regulatory Information Service

Allthe announcements listed below can be obtained from the London Stock Exchange website, www.londonstockexchange.com/marketnews or from the Company's website, www.puricore.com

Date

Headline

30/04/2009

PuriCore Plc - Holding(s) in Company

28/04/2009

PuriCore Plc - Q1 Interim Management Statement

28/04/2009

PuriCore Plc - Final Results

17/02/2009

PuriCore Plc - Holding(s) in Company

10/02/2009

PuriCore Plc - Director/PDMR Shareholding

09/02/2009

PuriCore Plc - Director/PDMR Shareholding

06/02/2009

PuriCore Plc - Holding(s) in Company

04/02/2009

PuriCore Plc - Blocklisting Six Monthly Return

03/02/2009

PuriCore Plc - Director/PDMR Shareholding

02/02/2009

PuriCore Plc - Trading Statement

02/01/2009

PuriCore Plc - Director/PDMR Shareholding

29/12/2008

PuriCore Plc - Director/PDMR Shareholding

12/11/2008

PuriCore Plc - Director/PDMR Shareholding

03/11/2008

PuriCore Plc - Notification of PDMR Interest - Option Award

24/10/2008

PuriCore Plc - Receives an order from Safeway

13/10/2008

PuriCore Plc - Board and Organisational Changes

13/10/2008

PuriCore Plc - Interim Management Statement

01/10/2008

PuriCore Plc - Raises $9.74 million

11/09/2008

PuriCore Plc - Holding(s) in Company

04/09/2008

PuriCore Plc - Holding(s) in Company

03/09/2008

PuriCore Plc - Holding(s) in Company

03/09/2008

PuriCore Plc - PDMR Dealings

29/08/2008

PuriCore Plc - Total Voting Rights

29/08/2008

PuriCore Plc - Interim Results

26/08/2008

PuriCore Plc - Result of General Meeting

22/08/2008

PuriCore Plc - Result of Open Offer

04/08/2008

PuriCore Plc - Blocklisting Six Monthly Return

30/07/2008

PuriCore Plc - PuriCore Wins Food Safety Contract

30/07/2008

PuriCore Plc - Trading Update

30/07/2008

PuriCore Plc - Placing and Open Offer

02/07/2008

PuriCore Plc - Awarded Contract

01/07/2008

PuriCore Plc - Patent Decision and Debt Financing

26/06/2008

PuriCore Plc - AGM Statement

19/06/2008

PuriCore Plc - Piper Jaffray European Conference

09/06/2008

PuriCore Plc - Natural Resources & Infrastructure Conference

02/06/2008

PuriCore Plc - Annual Report and Accounts

 

2. Documents filed at Companies House

Copies of these documents can be obtained from Companies House at Crown Way, Maindy, Cardiff CF14 3UZ or from Companies House website www.companieshouse.co.uk.

Date

Document

Description

12/05/2009

363a

Annual Return

12/05/2009

288c

Change in Details of Director

12/05/2009

288c

Change in Details of Director

20/01/2009

353a

 Location of Register of Members 

06/11/2008 

288b

Terminating Appointment of Director

02/10/2008 

288b

Terminating Appointment of Director

02/10/2008 

288b

Terminating Appointment of Director

18/09/2008 

RES04

Written Resolutions

10/09/2008 

122

Notice regarding shares

04/08/2008 

AA

Group of Companies' Accounts 

23/07/2008 

RES01

Resolutions

14/07/2008 

Mem/Arts

Articles of Association 

27/05/2008 

363a

Annual Return

27/05/2008 

353

Location of Register of Members

21/05/2008 

88(2)

Return of Allotment of Shares 

 

3. Documents published and sent to shareholders 

Date

Document Description

02/06/2008

Annual Report and Accounts 2007, Proxy Form, and Notice of Annual General Meeting

04/08/2008

Placing and Open Offer Prospectus, Application, and Proxy Form

11/05/2009

Annual Report and Accounts 2008, Proxy Form, and Notice of Annual General Meeting

 

4. Documents filed with the UKLA Documents Viewing Facility

Date

Document Description

05/05/2009

Annual Report and Accounts 2008

29/08/2008

Half-Yearly Report 2008

04/08/2008

Placing and Open Offer Prospectus

03/06/2008

Annual Report and Accounts 2007

Copies of these documents can be obtained from:

 

Registered Office

PuriCore plc

58 Davies Street

London

W1K5JF

UK

 

Andrea Holtzman Drucker

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUDGGZKKVNGLZM
Date   Source Headline
21st Nov 20177:00 amRNSRealm: Preclinical Data on PR022 Published
17th Nov 20177:00 amRNSDirectorate Change
2nd Nov 20177:00 amRNSRealm Therapeutics to Present at BIO-Europe® 2017
30th Oct 20177:00 amRNSRealm Presents Data at ACAAI Scientific Meeting
18th Oct 20177:00 amRNSHolding(s) in Company
18th Oct 20177:00 amRNSBlock Listing Application
17th Oct 20176:28 pmRNSHolding(s) in Company
16th Oct 20173:39 pmRNSHolding(s) in Company
16th Oct 20177:00 amRNSRealm Therapeutics to speak at BIO Investor Forum
13th Oct 20172:20 pmRNSHolding(s) in Company
13th Oct 20172:17 pmRNSHolding(s) in Company
12th Oct 20175:48 pmRNSHolding(s) in Company
12th Oct 20173:07 pmRNSRealm Therapeutics: Completion of £19.3m Placing
12th Oct 201711:04 amRNSHolding(s) in Company
12th Oct 201710:58 amRNSHolding(s) in Company
9th Oct 201711:35 amRNSResult of General Meeting
22nd Sep 20177:00 amRNSProposed Placing to raise £19.3 million
22nd Sep 20177:00 amRNSInterim Results
21st Sep 20176:01 pmRNSProposed Placing to raise £19.3 million
21st Sep 20176:00 pmRNSInterim Results
11th Sep 20177:00 amRNSFDA Permits PR013 to Proceed to Phase II Trial
7th Sep 20177:00 amRNSConference Presentation
18th Aug 20177:00 amRNSBlock listing Interim Review
2nd Aug 20177:00 amRNSSubmission of Investigational New Drug Application
6th Jul 20177:00 amRNSPresentation at World Congress on Inflammation
14th Jun 20177:09 amRNSPresentation at 2017 Marcum Microcap Conference
6th Jun 201711:05 amRNSResult of AGM
11th May 201712:21 pmRNSNotice of AGM
23rd Mar 20172:57 pmRNSAnnual Report and Accounts Available
23rd Mar 20177:00 amRNSFinal Results and Business Update
6th Mar 20177:00 amRNSConference Presentation
28th Feb 20177:00 amRNSFDA permits PR022 to Proceed to Phase 2 Trial
20th Feb 20177:00 amRNSBlock listing Interim Review
13th Feb 20177:00 amRNSPresentation at BIO CEO & Investor Conference
30th Jan 20177:00 amRNSResearch Update - Submission of first IND
5th Jan 20177:00 amRNSConference Presentations
4th Jan 20177:00 amRNSGrant of Options
21st Dec 20167:00 amRNSPDMR dealing
16th Dec 20167:00 amRNSIvan Gergel appointed as Non-Executive Director
7th Dec 20167:00 amRNSChange of name to Realm Therapeutics
18th Nov 20167:00 amRNSGrant of Options
17th Nov 20167:00 amRNSHolding(s) in Company
16th Nov 20167:00 amRNSDevelopment Programmes Update & Company Renaming
10th Oct 20167:00 amRNSCompletion of Supermarket Retail Business Disposal
7th Oct 20165:52 pmRNSCompletion of Supermarket Retail Business Disposal
6th Oct 201611:43 amRNSResult of General Meeting
23rd Sep 20162:47 pmRNSDirector/PDMR Dealing
22nd Sep 20162:15 pmRNSGrant of Options
20th Sep 20167:00 amRNSHalf-year Report
20th Sep 20167:00 amRNSProposed Disposal of Supermarket Retail Business

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.